RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Kun Zhang to Prostatic Neoplasms

This is a "connection" page, showing publications Kun Zhang has written about Prostatic Neoplasms.
Connection Strength

3.808
  1. Zhang W, Zhang K. A transcriptomic signature for prostate cancer relapse prediction identified from the differentially expressed genes between TP53 mutant and wild-type tumors. Sci Rep. 2022 06 22; 12(1):10561.
    View in: PubMed
    Score: 0.477
  2. Zhang W, Nicholson T, Zhang K. Deciphering the Polygenic Basis of Racial Disparities in Prostate Cancer By an Integrative Analysis of Genomic and Transcriptomic Data. Cancer Prev Res (Phila). 2022 03 01; 15(3):161-171.
    View in: PubMed
    Score: 0.467
  3. Lu Y, Edwards A, Chen Z, Tseng TS, Li M, Gonzalez GV, Zhang K. Insufficient Lycopene Intake Is Associated With High Risk of Prostate Cancer: A Cross-Sectional Study From the National Health and Nutrition Examination Survey (2003-2010). Front Public Health. 2021; 9:792572.
    View in: PubMed
    Score: 0.460
  4. Chen Z, Cao B, Edwards A, Deng H, Zhang K. A deep imputation and inference framework for estimating personalized and race-specific causal effects of genomic alterations on PSA. J Bioinform Comput Biol. 2021 08; 19(4):2150016.
    View in: PubMed
    Score: 0.446
  5. Zhang W, Dong Y, Sartor O, Zhang K. Comprehensive Analysis of Multiple Cohort Datasets Deciphers the Utility of Germline Single-Nucleotide Polymorphisms in Prostate Cancer Diagnosis. Cancer Prev Res (Phila). 2021 07; 14(7):741-752.
    View in: PubMed
    Score: 0.440
  6. Zhang W, Dong Y, Zhang K. Gene expression analysis reveals a pitfall in the molecular research of prostate tumors relevant to Gleason score. J Bioinform Comput Biol. 2020 10; 18(5):2050032.
    View in: PubMed
    Score: 0.422
  7. Zhang W, Dong Y, Sartor O, Flemington EK, Zhang K. SEER and Gene Expression Data Analysis Deciphers Racial Disparity Patterns in Prostate Cancer Mortality and the Public Health Implication. Sci Rep. 2020 04 22; 10(1):6820.
    View in: PubMed
    Score: 0.411
  8. Zhang W, Flemington EK, Deng HW, Zhang K. Epigenetically Silenced Candidate Tumor Suppressor Genes in Prostate Cancer: Identified by Modeling Methylation Stratification and Applied to Progression Prediction. Cancer Epidemiol Biomarkers Prev. 2019 01; 28(1):198-207.
    View in: PubMed
    Score: 0.368
  9. Zhang W, Edwards A, Fan W, Flemington EK, Zhang K. miRNA-mRNA correlation-network modules in human prostate cancer and the differences between primary and metastatic tumor subtypes. PLoS One. 2012; 7(6):e40130.
    View in: PubMed
    Score: 0.239
  10. Liu S, Zhang Q, Chen C, Ge D, Qu Y, Chen R, Fan YM, Li N, Tang WW, Zhang W, Zhang K, Wang AR, Rowan BG, Hill SM, Sartor O, Abdel-Mageed AB, Myers L, Lin Q, You Z. Hyperinsulinemia enhances interleukin-17-induced inflammation to promote prostate cancer development in obese mice through inhibiting glycogen synthase kinase 3-mediated phosphorylation and degradation of interleukin-17 receptor. Oncotarget. 2016 Mar 22; 7(12):13651-66.
    View in: PubMed
    Score: 0.077
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support